{"article_link": "https://doi.org/10.1016/j.celrep.2023.113568", "data": [{"id": "data_1", "omics": "Transcriptomics", "link": "https://github.com/petebio/Gene_regulatory_network_analysis", "format": "txt/csv", "source": "Gene Expression Omnibus (GEO)", "public_id": "GSE236775"}, {"id": "data_2", "omics": "Epigenomics", "link": "https://github.com/petebio/Gene_regulatory_network_analysis", "format": "txt/csv", "source": "DNaseI-seq data from Assi et al. (2019)", "public_id": "GSE108316"}, {"id": "data_3", "omics": "Single-cell RNA-seq", "link": "https://github.com/petebio/Gene_regulatory_network_analysis", "format": "fastq", "source": "Gene Expression Omnibus (GEO) - subset of GSE236775", "public_id": "GSE236775"}, {"id": "data_4", "omics": "Epigenomics", "link": "https://github.com/petebio/Gene_regulatory_network_analysis", "format": "bam", "source": "ATAC-seq from this study", "public_id": "GSE236775"}, {"id": "data_5", "omics": "Epigenomics", "link": "https://github.com/petebio/Gene_regulatory_network_analysis", "format": "bam", "source": "ChIP-seq from this study", "public_id": "GSE236775"}], "analyses": [{"id": "analysis_1", "analysis_name": "Gene co-expression network analysis", "analysis_data": ["data_1", "data_2"], "label": {"FLT3-ITD status": ["positive", "negative"]}}, {"id": "analysis_2", "analysis_name": "shRNA drop-out screen", "analysis_data": ["data_1"], "label": {"cell type": ["MV4-11", "MOLM14"], "condition": ["in vitro", "in vivo (NSG mice)"]}}, {"id": "analysis_3", "analysis_name": "Drug response analysis (CBFβi)", "analysis_data": ["data_1", "data_3"], "label": {"treatment": ["CBFβi", "DMSO"]}}, {"id": "analysis_4", "analysis_name": "Mutation-specific regression analysis", "analysis_data": ["data_1", "data_2"], "label": {"mutation status": ["FLT3-ITD", "FLT3-ITD/NPM1", "wild-type"]}}, {"id": "analysis_5", "analysis_name": "Perturbation analysis (ATAC-seq)", "analysis_data": ["data_1", "data_2", "data_4"], "label": {"perturbation": ["RUNX1 depletion", "control"]}}, {"id": "analysis_6", "analysis_name": "Drug response comparison (AML vs. healthy PBSCs)", "analysis_data": ["data_1", "data_3"], "label": {"cell type": ["AML", "healthy PBSCs"], "treatment": ["CBFβi", "DMSO"]}}], "results": [{"analysis_id": "analysis_1", "metrics": "Jaccard similarity", "value": "0.79", "features": ["RUNX1 module", "ETS family", "AP-1 family", "C/EBP family", "NFiX module", "FOX family", "EGR family"]}, {"analysis_id": "analysis_2", "metrics": "Hit rate", "value": "approximately 50%", "features": ["RUNX1", "NFIL3", "EGR1", "FOS", "CEBPA", "KLF2", "IRX3", "MYB", "DUSP6", "IL8", "NFATC1", "FOXC1"]}, {"analysis_id": "analysis_3", "metrics": "Viability reduction (fold change)", "value": "-0.7", "features": ["RUNX1", "NFiX", "EGR1", "AP-1", "C/EBP"]}, {"analysis_id": "analysis_4", "metrics": "Fold change (log2)", "value": "2.0", "features": ["CSF1R", "IRF8", "DUSP5", "DUSP6", "MATK", "KLF2", "KLF6"]}, {"analysis_id": "analysis_5", "metrics": "Open chromatin regions", "value": "2,000±500 (gained and lost)", "features": ["RUNX1 module", "C/EBP-AP-1 composite motif", "NFiX module"]}, {"analysis_id": "analysis_6", "metrics": "Viability reduction (fold change)", "value": "-1.2", "features": ["RUNX1", "NFiX", "EGR1"]}]}